Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells

Details for Australian Patent Application No. 2006214325 (hide)

Owner ZymoGenetics, Inc. National Jewish Medical and Research Center

Inventors Leung, Donald Y. M.; Gross, Jane A.; Bilsborough, Janine

Agent Griffith Hack

Pub. Number AU-B-2006214325

PCT Pub. Number WO2006/088955

Priority 60/653,114 14.02.05 US; 60/716,762 13.09.05 US; 60/749,952 13.12.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 5 April 2012

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/088955 Priority application(s): WO2006/088955

13 September 2007 Amendment Made

  The nature of the amendment is: Amend the coinventor name from Billsborough, Janine to Bilsborough, Janine

5 April 2012 Application Accepted

  Published as AU-B-2006214325

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214326-Methods of predicting therapeutic response in atopic dermatitis to IL-31 antagonists

2006214321-CD38 modulated chemotaxis